An unexpected significant increase in deaths in the lenalidomide arm of the trial lead the FDA to stop it. But I don't believe that is the whole story and this is too good a drug to throw out.
I have two posts on my blog at bkoffman.blogspot.com that deal with this that also have links to other news.